rs11550348

This variant is located in the IRF2BP1 gene.

GWAS Catalog Trait Associations (9)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

hematocrit

Allele A
OR 0.03
p 4.0e-32
N 394,642
Large GWAS
European

low density lipoprotein cholesterol measurement

Koskeridis F et al. Pleiotropic genetic architecture and novel loci for C-reactive protein levels. Nature Communications 13(1):6939 (2022)
Allele A
OR 0.02
p 3.0e-23
N 361,194
Large GWAS
European

high density lipoprotein cholesterol measurement

Koskeridis F et al. Pleiotropic genetic architecture and novel loci for C-reactive protein levels. Nature Communications 13(1):6939 (2022)
Allele A
OR 0.03
p 4.0e-15
N 361,194
Large GWAS
European

total cholesterol measurement

Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele G
OR 0.02
p 4.0e-14
N 570,819
Major Consortium StudyLarge GWAS
multi-ancestry

prothrombin time measurement

Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele G
OR 0.04
p 1.0e-12
N 165,202
Major Consortium StudyLarge GWAS
European

osteoarthritis, hand

Hatzikotoulas K et al. Translational genomics of osteoarthritis in 1,962,069 individuals. Nature 641(8065):1217-1224 (2025)
Allele A
OR 0.85
p 2.0e-10
N 725,493
Large GWAS
multi-ancestry

ClinVar annotation

Benign★★★
2 submitters1 publication
View on ClinVar →

About IRF2BP1

Enables transcription corepressor activity and ubiquitin protein ligase activity. Involved in protein polyubiquitination. Acts upstream of or within negative regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]

View all IRF2BP1 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…